Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 39: 488-495, 1993;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bhayana, V.
Right arrow Articles by Henderson, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bhayana, V.
Right arrow Articles by Henderson, A. R.

Clinical Chemistry, Vol 39, 488-495, Copyright © 1993 by American Association for Clinical Chemistry

Diagnostic evaluation of creatine kinase-2 mass and creatine kinase-3 and -2 isoform ratios in early diagnosis of acute myocardial infarction

V Bhayana, S Cohoe, FY Leung, G Jablonsky and AR Henderson
Department of Clinical Biochemistry, University Hospital (University of Western Ontario), London, Canada.

The diagnostic efficacy of creatine kinase (CK) isoforms (CK-3 and CK- 2) was compared with measurement of CK-2 mass concentrations for the early diagnosis of myocardial infarction (MI). Serial serum samples drawn from 76 patients with confirmed MI and 55 non-MI patients were used for determining CK-2 mass concentrations and the MM3/MM1 (CK-3 isoforms) and MB2/MB1 (CK-2 isoforms) ratios. We compared the diagnostic utility of each by receiver-operating-characteristic (ROC) curve and likelihood ratio analyses. Our results indicate that all three tests were ineffective within the first 4 h after the onset of chest pain. All three were most effective at 4-18 h after onset, but both CK-3 and CK-2 isoform ratios were less effective than CK-2 mass concentrations in the next 6-h period (18-24 h). In the critical time between 3 and 6 h, the diagnostic performance of all three was comparable.


The following articles in journals at HighWire Press have cited this article:


Home page
 NEJMHome page
J.H. Keffer, V. Bhayana, A. R. Henderson, D. A. Propp, G. E. Lane, G. Gilson, R. Roberts, P. Puleo, and C. W. Hamm
Subforms of Creatine Kinase MB in the Diagnosis of Myocardial Infarction
N. Engl. J. Med., March 2, 1995; 332(9): 608 - 610.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American Association for Clinical Chemistry.